NOVOPEN ECHO Insulin Pen Device The FDA has granted clearance for NovoPen Echo, the first insulin pen device with half-unit dosing and a memory function that records the dose and elapsed time.

And while insulin pens are popular in Europe and Asia, only about 800,000 of the 4 million U.S. diabetics who need daily insulin injections use a pen. Most use syringes and insulin vials.